Singapore and Hong Kong as Safe Havens — Where Is Capital Flowing in 2026?
As a Singaporean investor, I had largely ignored SGX for years. The STI had a reputation as a slow, boring market — banks, REITs, and not much else. Most of the action was in US equities or the occasional China tech name. When I started building SGX positions earlier this year, it was primarily for diversification away from US equities, not because I suddenly believed in the STI story.
But looking at the data now, I think something more interesting has happened. The influx of institutional and HNWI money into Singapore as a safe haven has effectively re-rated the market. The capital flowing in from Dubai, Hong Kong, and elsewhere isn’t just sitting in bank accounts — it’s finding its way into SGX stocks, pushing the index to all-time highs. Local retail investors like me are benefiting from a re-rating driven by money we had nothing to do with.
And it’s worth understanding why — because it has implications for where to put money next.
What’s happening out there
You don’t have to follow bond markets closely to notice what’s happening. US 10-year yields at 4.50%, the 30-year approaching 5%. UK 30-year Gilts at their highest since 1998. Japan’s 10-year at its highest since 1997. All at the same time. Not a coincidence — just the inevitable consequence of years of fiscal overreach. The US running 9% fiscal deficits, Japan finally normalising after decades of near-zero rates, the UK’s debt servicing costs building for years. The direction was always going to be this way.
The Iran conflict has added another layer on top of that. The Strait of Hormuz closing to commercial shipping in late February has done a lot more damage than just pushing oil above US$100. More than a third of globally traded fertilizer passes through that waterway — urea prices are up 26% since the conflict began, hitting farmers across Asia, India, and Brazil right at planting season. Shipping insurance is spiking. Food prices are rising. There’s even a threat to undersea internet cables running through Iranian territorial waters. Put it all together and you have the stagflation setup that most investors were hoping to avoid — costs up, confidence down, growth slowing.
Capital moves in this environment. The question is where.
Dubai used to be one of the answers
For a few years, one of the answers for HNWI and family offices was Dubai. From 2022 onwards — partly because Singapore’s 2023 money laundering case and the subsequent MAS tightening of KYC requirements made onboarding longer and more demanding — family offices and UHNW individuals started flowing toward the UAE in meaningful numbers. By late 2024, Dubai’s family offices were managing over US$1.2 trillion in assets, and the UAE was the top destination globally for relocating millionaires. It looked like the safe harbour of choice for private wealth.
Then the Iran war started on 28 February 2026. The UAE took direct hits. Dubai International Airport was damaged. The property market froze — transaction volumes halved within weeks, developers sold off sharply. The safe-haven narrative that Dubai had been selling so hard fell apart in a matter of days. Will it recover? I’m not sure it ever fully does. As a retail investor sitting in Singapore, I’ve watched some of that capital flow directly into the two markets I’ve been paying close attention to this year — Singapore and Hong Kong.
Singapore — the defensive safe haven
The STI (Straits Times Index — Singapore’s benchmark index of 30 large-cap stocks, roughly equivalent to the Dow Jones) is up 8.36% year-to-date and 28.53% year-on-year, touching all-time highs above 5,000 points — almost neck and neck with the S&P 500’s 10.28% YTD and 27.93% YoY over the same period. The difference is Singapore got there with far less volatility and a very different risk profile. The capital flows are backing that up.
Why Singapore? Think about what wealthy families and institutions are actually looking for right now. They want somewhere that isn’t picking sides in a conflict, where their money isn’t suddenly locked up, where the rules don’t change overnight. Singapore ticks all of those boxes — geopolitically neutral, no capital controls, rule of law that’s consistently applied, a government that has been stable for decades. MAS is strict, but you know exactly what to expect. That predictability is the product. The reason capital comes here is trust.
To be clear — Singapore’s safe-haven appeal is in equities and currency, not bonds. The US 10-year at 4.50% still wins on yield. With T-bill returns declining as central banks ease, income seekers are being pushed toward short-duration credit, not SGS bonds. What Singapore offers is currency appreciation and equity dividends — the SGD itself is part of the return.
MAS reinforced the message just this week, announcing it is cutting private bank account opening times from a median of six weeks to within a month. MAS MD Chia Der Jiun said it plainly: “In a world buffeted by shocks and uncertainty, there will be demand for safety and stability. The attributes of safety and stability have been Singapore’s enduring advantage.”
So where is that capital landing on SGX?
Looking at the FTSE ST sector data as at 30 April 2026, the flows are pretty clear.
| FTSE ST Sector | YTD % (Apr 2026) |
|---|---|
| Basic Materials | +19% |
| Consumer Goods | +1% |
| Consumer Services | −1% |
| Financial Services | +21% |
| Financials (Banks) | +6% |
| Health Care | +3% |
| Industrials | +13% |
| Oil & Gas | +37% |
| Real Estate H&D | +10% |
| Real Estate (REITs) | −1% |
| Technology | +44% |
| Telecom | +1% |
| Travel & Leisure | −3% |
| Utilities | +7% |
Source: SGX API, closing values as at 30 April 2026. YTD = Dec 2025 → Apr 2026. Price return. FTSE ST = FTSE Straits Times sector indices, SGX’s equivalent of S&P GICS sector classifications.
Look at the table and a few things jump out immediately. Technology at +44% leads everything — though I’d caution that SGX’s technology sector isn’t what most people picture. There’s no Grab, no Sea Limited here. It’s semiconductor equipment, electronics manufacturing, advanced materials — a handful of names really. I picked up a few of these names earlier this year and one of them, UMS Integration (SGX: 558), has been the standout at +141% YTD. Didn’t fully anticipate that kind of run, but the supply chain reshoring thesis played out faster than expected.
Industrials is where I’ve been most deliberate. It’s one of my core strategy sectors for 2026 — not because of the YTD number, but because of what’s underneath it. SGX’s industrial names aren’t conglomerates; they’re focused businesses with real order books. The Iran conflict has driven defence and shipbuilding demand. But the longer-term story is AI, robotics, and advanced manufacturing — Singapore is actively building that out. ST Engineering sits at the intersection of both, up around 33% YTD and one of my picks here.
Healthcare is also a core sector for me, but SGX is honestly quite thin here. It’s mostly hospital groups and clinic operators — good businesses, but not the kind of growth I’m looking for. The +3% YTD says it all. If you want biotech, AI drug discovery, clinical-stage innovation, you have to go to Hong Kong. I’ll come back to that.
Consumer is the one area where SGX doesn’t really serve my strategy. The two sub-sectors — Consumer Goods (+1%) and Consumer Services (−1%) — net to basically zero. One is food and staples, the other is transport, gaming, hospitality. Both fine businesses, but what I’m actually looking for in Consumer Discretionary are companies building AI infrastructure and digital platforms on top of a consumer base. That kind of name simply doesn’t exist on SGX.
As most of us know, the STI has always been heavily skewed toward Financials and REITs — the three banks alone make up close to half the index, and REITs have been the go-to income play for over a decade. In 2026, those two are telling very different stories.
Financials are doing well — the banks have been direct beneficiaries of safe-haven inflows, with DBS, OCBC, and UOB all reporting strong wealth AUM growth as net new money floods in. Dividend yields of 5–6% provide a solid floor. I also hold MoneyMax Financial Services (SGX: 5WJ) — a pawnbroker and luxury goods lender — up 103% YTD. Gold at all-time highs, wealthy individuals relocating to Singapore, luxury items being used for short-term liquidity. Didn’t plan it as a safe-haven play, but it turned out to be exactly that.
REITs are the opposite story. S-REITs used to be the reliable income compounder — 5–7% yields, stable capital values. I still hold some from earlier positions. But the index fell 6.4% in Q1 2026 and dropped 7% in March alone against the STI’s 2% pullback. The issue is structural — higher refinancing costs are compressing distributions. A 5.9% REIT yield looks good against Singapore’s 2.07% bond yield, but less so when the US 10-year is at 4.50%. I’m not adding to REIT positions right now.
Hong Kong — a different kind of opportunity
Before getting into the numbers, it’s worth remembering where Hong Kong was coming from. The 2019 protests, the National Security Law in 2020, zero-COVID, a multi-year property slump — for the better part of six years, capital was leaving Hong Kong, much of it ending up in Singapore. Then in August 2023, Singapore’s own S$3 billion money laundering case broke. MAS tightened KYC requirements. Some of that capital started looking elsewhere again — Hong Kong picked up some of it, Dubai picked up some too. So 2026 isn’t Hong Kong suddenly rediscovering its mojo from scratch. It’s a market recovering from being beaten down for years, with a valuation case that was always there but took time for investors to revisit.
The numbers since then have been pretty striking. The Hang Seng surged 28% in 2025 — outperforming the US, Europe, and Mainland China. HKEX reclaimed the top global IPO ranking with US$36 billion raised, up 218% year-on-year. Q1 2026 kept going with HK$110 billion in IPO proceeds, a five-year quarterly record. Wealth management AUM crossed US$4.5 trillion. These aren’t small numbers for a market that was being written off not long ago.
What’s pulling capital in? Largely China’s push to build out its own technology stack — semiconductors, AI, biotech, advanced manufacturing. HKEX is where those companies come to list, because it gives them the legal framework, liquidity, and international investor base that Mainland exchanges can’t. For investors who want a piece of that story, Hong Kong is the access point.
So where is the capital landing?
| HSCI Sector | YTD % (Apr 2026) |
|---|---|
| Consumer Discretionary | −10% |
| Consumer Staples | +1% |
| Conglomerates | +17% |
| Energy | +32% |
| Financials | +8% |
| Healthcare | +2% |
| Industrials | +15% |
| Information Technology | −17% |
| Materials | −1% |
| Properties & Construction | +12% |
| Telecom | +3% |
| Utilities | +6% |
Source: Hang Seng Indexes Company Ltd, HSCI factsheet as at 30 April 2026. YTD = Jan → Apr 2026. Price return. HSCI = Hang Seng Composite Index, Hong Kong’s broad market equivalent of the S&P 500.
Energy at +32% makes sense — same Iran war tailwind as Singapore, nothing complicated there.
Industrials at +15% is a sector I’m supposed to like — it’s one of my core strategy sectors — but I’m cautious about the HK version of it. The index here is largely Mainland China manufacturers: machinery, chemicals, steel, EVs. And China’s manufacturing has been flooding global markets with cheap output for years, picking up anti-dumping probes from the US, EU, India, and Brazil along the way. Industry utilisation rates sit at just 74.9%. That’s not a sector I want broad exposure to. The +15% is a bounce from oversold levels, not a sign that the underlying businesses have turned a corner.
My only HK Industrials exposure is WeRide and Pony.ai — both dual-listed in the US and HK — and that’s a specific autonomous driving call, not a broad sector bet. Both are already running commercial robotaxi operations with revenues growing fast. The market just hasn’t priced it in yet.
Healthcare is where HK genuinely excites me. The +2% YTD doesn’t tell the real story. What HKEX has built over the past few years — a proper biotech listing ecosystem with pre-revenue pathways, AI drug discovery companies, clinical-stage innovators — is something SGX simply can’t match. The quality of investors coming into these deals, global pharma names and sovereign wealth funds as cornerstone investors, tells you this isn’t just a local story. I hold WuXi AppTec (2359.HK), a pharmaceutical CRDMO at the intersection of drug R&D and China’s AI drug discovery buildout, up 27% YTD as of late May. And I’m actively looking at more names in this space.
Consumer is straightforward — I’m not playing it through HK. Consumer Discretionary is down 10% and Consumer Staples barely positive, which makes sense given China’s domestic consumption headwinds. That said, two of the names I hold that technically sit in Consumer Discretionary aren’t really consumer plays — they’re AI infrastructure and EV/AV companies that happen to be classified there. Both are commercialising but the stock prices haven’t caught up yet. Same story as the autonomous driving names.
Then there’s the one that really puzzles people at first glance. Information Technology is down 17% YTD — at a time when everyone’s talking about China AI, DeepSeek, Tencent’s AI push. How does that make sense? The way I see it: the AI narrative is real, the earnings aren’t there yet. Tencent is down 10–15% YTD despite growing revenue 9% with operating margins at a decade high. The money is going into AI; the returns from AI aren’t flowing back to shareholders yet. Investors are running out of patience waiting for the monetisation story to click.
Overall, my HK exposure is still relatively early-stage. I’m planning to do more due diligence on names across healthcare and the AI/AV space before adding further positions.
The risk that separates them
Before the regulatory risk, there’s the valuation risk. Within HK’s IT sector, there are individual names up over 1,000% YTD on pure AI narrative — pre-profit, high beta, no earnings to speak of. The index is down 17% while individual names are up 11x. That’s how bifurcated this market is. In a correction, those names give back gains fast — and that’s the kind of volatility Singapore’s dividend-heavy market simply doesn’t carry.
Then there’s the regulatory risk. On 22 May 2026, China’s CSRC and seven other agencies jointly cracked down on Tiger Brokers, Futu, and Longbridge for cross-border securities business. Futu was fined 1.85 billion yuan, Tiger 410 million yuan. Both stocks fell 25–40% the same day. A two-year wind-down was imposed — mainland clients can only sell, not buy, during that period. With combined client assets near HK$290 billion, the liquidity impact on Hong Kong markets is real. The HSI has fallen around 5% from its 7 May peak.
That’s China policy risk in one week. No warning, no consultation, just an announcement and a market reaction.
Singapore is different. MAS gives notice. There are transition periods. The rules are published and followed. You might not always like what MAS does, but you won’t be blindsided by it. That consistency is exactly what capital is paying for right now — and it’s why I hold my Singapore positions with more conviction than my HK ones.
How I’m thinking about this
That’s the macro picture. Here’s how I’ve personally positioned around it.
Both Singapore and Hong Kong are benefiting from the same macro shift: capital rotating out of the US and out of the Middle East, looking for credible alternatives. But they’re serving different mandates.
Singapore is the cleaner safe haven — fiscal strength, currency stability, regulatory predictability, and dividend yields that hold up in any environment. My SGX positions are aligned with where the safe-haven inflows are landing. The stockpicking worked out, even if diversification was the primary motivation.
Hong Kong is the better growth bet when China allows it to be. HKEX’s recovery is real — biotech pipeline, AI/AV commercialisation, reclaiming the global IPO crown. But I’m currently in selectively, focused on healthcare and autonomous driving — not as a broad market bet. The CSRC risk is real, and some of the chip and AI-related names are carrying the same FOMO-driven valuations as their US counterparts — in a correction, that froth unwinds faster and harder than Singapore’s dividend-heavy market. I size accordingly.
Singapore and Hong Kong are not the only markets capturing flows. For readers who want to look further afield, Brazil (EWZ +14% YTD) is riding commodity tailwinds from the Iran conflict’s impact on oil and fertilizer prices. Japan (EWJ +14% YTD) is benefiting from USD/JPY hovering around 159-160 — a weak yen makes Japanese exporters highly competitive. But for a Singapore-based investor, the yen currency risk cuts both ways — if the Bank of Japan hikes rates or intervenes aggressively to defend the 160 level, a strengthening yen could erode equity gains quickly. I’ve held off for now, but it stays on the radar.
None of these — Singapore, Hong Kong, Japan, or Brazil — is a replacement for my US equity positions. It’s diversification. And in a world where US Treasuries, Dubai as the wealth hub, and oil flowing freely through the Gulf are all under pressure simultaneously, that geographic spread feels more important than ever.
The author may hold positions in the stocks and assets mentioned in this post. This post is for informational and educational purposes only, and should not be construed as financial advice. Investors should conduct their own due diligence before making any investment decisions. The views expressed are solely the author’s own.